Christine Klein - Chair-Elect 2021-2023, Chair 2023-2025
Dr. Christine Klein is a Professor of Neurology and Neurogenetics. She studied medicine in Hamburg, Heidelberg, Luebeck, London, and Oxford (UK) with internships in Stockholm (Sweden), Rennes (France), Wollongong (Australia) and Vitebsk (Belarus). She moved to Boston from 1997-1999 for a fellowship in Molecular Neurogenetics with Dr. X.O. Breakefield and completed her neurology training at Luebeck University in 2004, followed by a series of summer sabbaticals in movement disorders with Dr. A.E. Lang in Toronto, Canada in 2004-2015. She was appointed Lichtenberg Professor at the Department of Neurology of Luebeck University in 2005, where her research has focused on the clinical and molecular genetics of movement disorders and its functional consequences. In 2009, Dr. Klein was appointed Schilling Professor of Clinical and Molecular Neurogenetics at the University of Luebeck and became Director of the newly founded Institute of Neurogenetics in 2013.
Dr. Klein has published >500 scientific papers and has an h-factor of 94 with ~35,000 citations. She is Deputy Editor of ‘Movement Disorders’ and Associate Editor of ‘Annals of Neurology’, served as chair of the Congress Scientific Program Committee of the 2016/2017 Annual Congresses of the International Parkinson and Movement Disorder Society, and served as President of the German Neurological Society (>10,000 members) from 2019-2020. Eleven of her former doctoral students or mentees have been promoted to the level of assistant, associate or full professor.
It is with enormous gratitude that I would like to acknowledge everything the International Parkinson and Movement Disorder Society has provided me with over the past almost quarter of a century including, but not limited to, excellent clinical training, outstanding research and networking opportunities, general as well as personal career support, a forum for inspiring discussions and exchange, the opportunity to work in international teams and, through this, connect with wonderful colleagues - some of whom became close friends -, all over the globe. As MDS-ES Chair, I would like to serve our Section in this spirit and would like to pursue three major goals:
- As a movement disorder specialist with a strong interest in (neurogenetics) research, I would like to strive for as close a link and alliance as possible between movement disorder clinicians and (basic) scientists in order to leverage all available potential to jointly develop new diagnostic and therapeutic options for our patients.
- As a grateful mentee on the one hand, and mentor on the other, promoting the careers of the young generation is very close to my heart.
- Europe is a wonderfully diverse and rich continent with respect to resources in movement disorders and beyond. Capitalizing on and fostering all of these opportunities in every individual European country and even more closely linking the European Section to our partner sections and to the international MDS umbrella organization would be an important goal and privilege as Chair of the MDS-ES.
Regina Katzenschlager – Secretary-Elect 2021-2023, Secretary 2023-2025
Dr. Katzenschlager trained in neurology and psychiatry in Vienna, Austria, and did a 3-year movement disorders fellowship at University College London, UK. She is now Head of the Department of Neurology and Geriatrics at Klinik Donaustadt and of Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders in Vienna, Austria. She is a Guest Professor at Vienna Medical University.
She has served as the President of the Austrian Neurological Society (2012-2014) and is a Board member of the Austrian PD Society.
Her research interests are focused on motor and non-motor problems in Parkinson´s disease and their treatment including clinical trials and evidence-based medicine.
She has served in several roles for the International Parkinson and Movement Disorder Society, including as faculty and course director, and as a Member of the Editorial Board of Movement Disorders, the Executive Committee of the European Section, and as Chair of the Liaison Committee.
She has been involved in evidence based medicine related work for many years and currently chairs the MDS Evidence Based Medicine Committee.
I have been involved in the activities of the International Parkinson and Movement Disorder Society (MDS) for years and have enjoyed witnessing its growth and its development into the leading global scientific organization in the field.
Having served the Society on several committees, including the Executive Committee of the European Section, and in my current role as chair of the Evidence Based Medicine Committee, I would be honored and delighted to continue to actively support the Society´s mission of enhancing awareness, providing education and supporting research. Among other aspects, I would like to see the European Section continue its successful efforts to reach out to a younger generation, to provide top quality education, and to make the geographical and gender distribution of its membership visible in active roles.
Maria Stamelou - Treasurer-Elect 2021-2023, Treasurer 2023-2025
Prof. Maria Stamelou studied Medicine in Thessaloniki, Greece. Neurology training and PhD in Marburg, Germany and fellowship in MDs in Queen Square, London. Prof. Stamelou is a Prof of Neurology in Philipps University, Marburg, Germany and Head of PD and MDs Dept, in HYGEIA Hospital, Athens, Greece. She has been involved in MDS since my early residency years. She has served as assistant editor for MDJ for 5 years, and recently as Associate Editor. She has been a member of the LEAP programme in 2015.
Inclusivity, diversity and pioneering new ways of effective interaction, is my vision for MDS-ES. As a former member of MDS-ES committee, I think there are numerous ways to improve the openness of this section in terms of engagement of younger members, women, people from lower income countries and every other group that may be under-represented. In particular now, this is more relevant than ever.
The new reality with the pandemic has opened new opportunities. How to take advantage of this and evolve this further should be in the focus of the next committee. The MDS-ES should be at the front of developing new tools to express the needs of our community and pioneer effective and, in fact, more inclusive and thus (even more effective) modern approaches to learning, academic excellence and supporting younger members to flourish in the field of Movement Disorders not despite but, because of, the new opportunities our times create.
Esther Cubo - Executive Committee Member 2021-2025
She has been able to create the movement disorders unit at Hospital Universitario of Burgos in Spain. She has trained young neurologists in movement disorders and is involved in different research networks, including the Scientific Committee of the European Huntington´s disease Network, the Parkinson´s disease longitudinal network in Spain, Chair of the Telemedicine of the International Parkinson´s disease and Movement Disorder Society (2015-2020), and member of the MDS-Rating Scale Scientific Committee. She is a well-published and widely recognized expert in clinical rating scales, clinical manifestations of movement disorders, neuroepidemiology, and telemedicine for Movement Disorders in underserved areas. Her publication record to date includes 168 peer-reviewed manuscripts in leading journals in the field, including Movement Disorders, Journal of Parkinson´s Disease, and Neurology. She was awarded the Presidential MDS award in 2014.
Her vision is to make positive and meaningful contributions to the Movement Disorder Society and improve patient care and research skills by inspiring young neurologists to be creatives. She would like to create opportunities and to build collaborations and networks with local Neurological and Biomedical Engineer Societies. Her mission is strongly determined by the responsibility of providing access to education in movement disorders to enthusiastic neurologists from underserved areas.
Margherita Fabbri - Executive Committee Member 2021-2025
Dr. Margherita Fabbri is Neurologist. She does her clinical and research activities at the Parkinson's disease Expert Centre and at the Clinical Investigation Center of the Toulouse University Hospital, within the team of Professor Olivier Rascol. Dr. Fabbri obtained medical degree in 2007 and her postgraduate Neurology degree in 2015 at the University of Bologna. She completed her PhD in 2019 at the Laboratory of Clinical Pharmacology and Therapeutics of the University of Lisbon, working on the clinical assessment and therapeutic strategies for advanced and late-stage Parkinson's disease (PD) patients. Dr. Fabbri’s main fields of interest are device-aided therapies for movement disorders, pharmacoepidemiology, late-stage PD and multidisciplinary models of care. On those topics, she has participated as co-investigator into two international JNPD funded projects, and has written as first authors, several paper in the last 5 years. In 2018, Dr. Fabbri was part of the LEAP MDS Class and since 2019 she is the Chair of the Young MDS Group (YMG). Within the YMG, she has developed several projects, including an on-going InnovationLab Projects, approved in 2019.
Being a member of the MDS and having access to all the educational tools of the Society has significantly impacted my career at the early beginning of my interest in movement disorders. Indeed, I definitively decided to dedicate myself to this field after the MDS Young Summer School in 2011, which was a remarkable experience for my career. For this reason, I principally dedicate my efforts into educational activities targeted to young members, trying to increase and facilitate their active participation within the Society. During the last ten years, the MDS made tremendous progress in the implementation and improvement of educational activities, reaching a huge number of new members. I would like to follow this path; I am convinced that this Society offers true educational and incomparable benefits for many physicians and health care professionals, all over the world. During my leadership experience within the YMG I was able to collaborate and coordinate members coming from all over the world into different projects and educational activities. I believe that this experience, as well as my active participation within the Moving Along Editorial Board and the Social Media Subcommittee, will facilitate my eventual activity as Executive Committee Member. I am aware on the functioning of the Society and I how to work within it. Young members represent one-third of the Society and I could well represent their needs within the Executive Committee.
Norbert Kovács - Executive Committee Member 2021-2025
Prof. Kovacs is Director of the Movement Disorders Unit at the University of Pécs in Hungary. He received his board certification in Neurology in 2008 and achieved his PhD from the University of Pécs in 2009. Prof. Kovacs has also received board certification in vascular neurology, and a Doctor of Science Degree from the Hungarian Academy of Sciences. Prof. Kovacs has organized numerous education, postgraduate and graduate workshops in the field of movement disorders and deep brain stimulation. Prof. Kovacs is also active in supervising PhD students and has authored 141 scientific articles.
I would like to initiate, promote, and encourage European collaboration between movement disorders specialist centers, including but not limiting to clinical care, clinical and epidemiological studies, training workshops and integrative care. I would also like to increase the knowledge of office-based neurologists through special training and activities.
Francesca Morgante - Executive Committee Member 2021-2025
Dr Francesca Morgante graduated with honours in Medicine in 2000 at University of Messina, Italy, where she also specialized in Neurology (2005) and got a PhD in Clinical Neuroscience (2009). In 2004-2005, she has been a research fellow at University of Toronto Movement Disorders Centre. She is an Associate Professor of Neurology at St George's University of London (UK) and University of Messina (Italy).
Her clinical work is focused on Movement Disorders, particularly on diagnosis of rare and unusual movement disorders syndrome and treatment of Parkinson’s disease, Tremor and Dystonia with device aided treatments. Her research work is focused on unravelling the mechanism of motor and non-motor symptoms of movement disorders, employing mainly neurophysiology.
She has served in the EC and as Secretary of Accademia LIMPE DISMOV (Italian society affiliated to MDS).
She serves in medical advisory boards of patients associations (Dystonia Europe and Dystonia Italy). She is an Associate Editor of Movement Disorders Journal (Gaps & Controversy section) and part of editorial board of Movement Disorders, Movement Disorders Clinical Practice and European Journal of Neurology.
The roles I have undertaken in the MDS and MDJ/MDCP journals have shaped my skills in dissemination of research and teaching and developments of educational resources. If I will be granted the opportunity to be part of the EC of MDS-ES, I will commit to expand the educational virtual portfolio and develop interactive tools to improve assessment and treatment of movement disorders, especially with device aided therapies and botulinum toxin. This is an urgent need in the current world situation due to CODIV-19 pandemic. More importantly, this would also favour access to practical educational resources for a larger group of people, including more senior members, health professionals with disabilities and young women with little children who would have difficulties to attend face to face training courses in the future.
Another aspect I would like to promote is the dissemination of medical and research information to the community of patients, working with European Patients’ association. In the current scenario, scientific news is quickly delivered to the public, but it is often misunderstood. My experience in patients’ association’s scientific advisory boards taught me that a partnership of scientific societies with them is crucial.
Finally, I envision to develop with the colleagues in the EC a platform favouring research collaboration between young members living in countries with poor access to research tools with research groups willing to mentor them.